FT Options LLC historic quarter change: USA Stocks, Added
In share positions in stocks (listed in the US), over 3 quarters from 2015-12-31 to 2016-09-30, FT Options LLC opened 67 positions, added to 27, reduced 22 and sold out of 51.
- Q3 2016: Stock PG; Country of operation United States; Class COM; Shares before 1,000.
- Q3 2016: Stock ABT; Country of operation United States; Class COM; Shares before 127,252.
- Q3 2016: Stock BMY; Country of operation United States; Class COM; Shares before 35,075.
- Q3 2016: Stock GILD; Country of operation United States; Class COM; Shares before 4,890.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1594954), 3 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-09). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2015-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | PG
PROCTER AND GAMBLE CO | United States | COM | 1,000 | 45,000 | +44,000 | $85,000 | $4,039,000 | +$3,954,000 | 2016-11-10 |
|---|
| Q3 2016 | ABT
ABBOTT LABS | United States | COM | 127,252 | 151,635 | +24,383 | $5,002,000 | $6,413,000 | +$1,411,000 | 2016-11-10 |
|---|
| Q3 2016 | BMY
BRISTOL MYERS SQUIBB CO | United States | COM | 35,075 | 73,537 | +38,462 | $2,580,000 | $3,965,000 | +$1,385,000 | 2016-11-10 |
|---|
| Q3 2016 | GILD
GILEAD SCIENCES INC | United States | COM | 4,890 | 16,421 | +11,531 | $408,000 | $1,299,000 | +$891,000 | 2016-11-10 |
|---|
| Q3 2016 | IBM
INTERNATIONAL BUSINESS MACHS | United States | COM | 100 | 3,925 | +3,825 | $15,000 | $623,000 | +$608,000 | 2016-11-10 |
|---|
| Q3 2016 | HRTX
HERON THERAPEUTICS INC | United States | COM | 5,156 | 29,937 | +24,781 | $93,000 | $516,000 | +$423,000 | 2016-11-10 |
|---|
| Q3 2016 | FIVE
FIVE BELOW INC | United States | COM | 14,695 | 24,830 | +10,135 | $682,000 | $1,000,000 | +$318,000 | 2016-11-10 |
|---|
| Q3 2016 | ORCL
ORACLE CORP | United States | COM | 1,000 | 7,300 | +6,300 | $41,000 | $287,000 | +$246,000 | 2016-11-10 |
|---|
| Q3 2016 | HUM
HUMANA INC | United States | COM | 7,850 | 9,300 | +1,450 | $1,412,000 | $1,645,000 | +$233,000 | 2016-11-10 |
|---|
| Q3 2016 | KLAC
KLA-TENCOR CORP | United States | COM | 1,717 | 5,017 | +3,300 | $126,000 | $350,000 | +$224,000 | 2016-11-10 |
|---|
| Q3 2016 | CHTR
CHARTER COMMUNICATIONS INC N | United States | CL A | 1,075 | 1,315 | +240 | $246,000 | $355,000 | +$109,000 | 2016-11-10 |
|---|
| Q3 2016 | HD
HOME DEPOT INC | United States | COM | 3,500 | 4,000 | +500 | $447,000 | $515,000 | +$68,000 | 2016-11-10 |
|---|
| Q2 2016 | BIIB
BIOGEN INC | United States | COM | 1,116 | 14,632 | +13,516 | $291,000 | $3,538,000 | +$3,247,000 | 2016-08-12 |
|---|
| Q2 2016 | CALM
CAL MAINE FOODS INC | United States | COM NEW | 22,892 | 82,081 | +59,189 | $1,188,000 | $3,638,000 | +$2,450,000 | 2016-08-12 |
|---|
| Q2 2016 | AAPL
APPLE INC | United States | COM | 5,357 | 28,844 | +23,487 | $584,000 | $2,757,000 | +$2,173,000 | 2016-08-12 |
|---|
| Q2 2016 | LGND
LIGAND PHARMACEUTICALS INC | United States | COM NEW | 864 | 8,467 | +7,603 | $93,000 | $1,010,000 | +$917,000 | 2016-08-12 |
|---|
| Q2 2016 | ACN
ACCENTURE PLC IRELAND | | SHS CLASS A | 2,600 | 5,100 | +2,500 | $300,000 | $578,000 | +$278,000 | 2016-08-12 |
|---|
| Q2 2016 | ESPR
ESPERION THERAPEUTICS INC NE | United States | COM | 31,296 | 80,799 | +49,503 | $529,000 | $798,000 | +$269,000 | 2016-08-12 |
|---|
| Q2 2016 | HUM
HUMANA INC | United States | COM | 6,578 | 7,850 | +1,272 | $1,203,000 | $1,412,000 | +$209,000 | 2016-08-12 |
|---|
| Q2 2016 | WDC
WESTERN DIGITAL CORP | United States | COM | 1,950 | 5,600 | +3,650 | $92,000 | $265,000 | +$173,000 | 2016-08-12 |
|---|
| Q2 2016 | M
MACYS INC | United States | COM | 7,500 | 12,500 | +5,000 | $331,000 | $420,000 | +$89,000 | 2016-08-12 |
|---|
| Q1 2016 | REGN
REGENERON PHARMACEUTICALS | United States | COM | 7,390 | 33,159 | +25,769 | $4,012,000 | $11,952,000 | +$7,940,000 | 2016-05-09 |
|---|
| Q1 2016 | AKBA
AKEBIA THERAPEUTICS INC | United States | COM | 36,156 | 389,919 | +353,763 | $467,000 | $3,513,000 | +$3,046,000 | 2016-05-09 |
|---|
| Q1 2016 | ESPR
ESPERION THERAPEUTICS INC NE | United States | COM | 10,000 | 31,296 | +21,296 | $223,000 | $529,000 | +$306,000 | 2016-05-09 |
|---|
| Q1 2016 | ABT
ABBOTT LABS | United States | COM | 122,300 | 135,300 | +13,000 | $5,492,000 | $5,660,000 | +$168,000 | 2016-05-09 |
|---|
| Q1 2016 | PTCT
PTC THERAPEUTICS INC | United States | COM | 1,575 | 22,954 | +21,379 | $51,000 | $148,000 | +$97,000 | 2016-05-09 |
|---|
| Q1 2016 | PFE
PFIZER INC | United States | COM | 18,070 | 21,686 | +3,616 | $583,000 | $643,000 | +$60,000 | 2016-05-09 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |